{"id":53620,"date":"2023-02-03T14:02:16","date_gmt":"2023-02-03T13:02:16","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/"},"modified":"2023-02-03T14:02:16","modified_gmt":"2023-02-03T13:02:16","slug":"tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/","title":{"rendered":"Tvardi Therapeutics to Present at the Guggenheim Securities Oncology Conference"},"content":{"rendered":"
\n

HOUSTON–(BUSINESS WIRE)–#IPF<\/a>–Tvardi Therapeutics, Inc. (\u201cTvardi\u201d), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced that the management team will present at the Guggenheim Securities Oncology Conference on Wednesday, February 8, 2023, in New York City as well as host one-on-one meetings throughout the day.\n<\/p>\n

<\/a><\/p>\n

\nPresentation Details:
\n
<\/b>Date: Wednesday, February 8, 2023
\n
Time: 1:00 p.m. EST
\n
Location: The St. Regis New York \u2013 Astor A\n<\/p>\n

\nAbout Tvardi Therapeutics<\/b>\n<\/p>\n

\nTvardi is a privately held, clinical-stage biopharmaceutical company developing small molecule inhibitors of STAT3, a key regulatory protein positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. STAT3 also plays a central role in the pathogenesis of many inflammatory and fibrotic diseases. The company\u2019s lead product, TTI-101, completed enrollment in its first-in-man Phase 1 trial of relapsed\/refractory patients with advanced solid tumors. To date, TTI-101 monotherapy has been well-tolerated and has clinical activity across a broad range of tumors including multiple durable radiographic objective responses. The company has now initiated Phase 2 clinical programs in hepatocellular carcinoma, metastatic breast cancer, and idiopathic pulmonary fibrosis. To learn more, please visit https:\/\/tvarditherapeutics.com\/<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nTvardi Investor Relations
\n
Sara Manning
\n
ir@tvardi.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

HOUSTON–(BUSINESS WIRE)–#IPF–Tvardi Therapeutics, Inc. (\u201cTvardi\u201d), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced that the management team will present at the Guggenheim Securities Oncology Conference on Wednesday, February 8, 2023, in New York City as well as host one-on-one meetings throughout the day. Presentation Details: Date: Wednesday, February 8, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53620","6":"format-standard","7":"category-industry"},"yoast_head":"\nTvardi Therapeutics to Present at the Guggenheim Securities Oncology Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tvardi Therapeutics to Present at the Guggenheim Securities Oncology Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"HOUSTON–(BUSINESS WIRE)–#IPF–Tvardi Therapeutics, Inc. (\u201cTvardi\u201d), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced that the management team will present at the Guggenheim Securities Oncology Conference on Wednesday, February 8, 2023, in New York City as well as host one-on-one meetings throughout the day. Presentation Details: Date: Wednesday, February 8, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-03T13:02:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230203005028\/en\/808014\/21\/Tvardi-Master_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Tvardi Therapeutics to Present at the Guggenheim Securities Oncology Conference\",\"datePublished\":\"2023-02-03T13:02:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\\\/\"},\"wordCount\":210,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230203005028\\\/en\\\/808014\\\/21\\\/Tvardi-Master_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\\\/\",\"name\":\"Tvardi Therapeutics to Present at the Guggenheim Securities Oncology Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230203005028\\\/en\\\/808014\\\/21\\\/Tvardi-Master_Logo.jpg\",\"datePublished\":\"2023-02-03T13:02:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230203005028\\\/en\\\/808014\\\/21\\\/Tvardi-Master_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230203005028\\\/en\\\/808014\\\/21\\\/Tvardi-Master_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tvardi Therapeutics to Present at the Guggenheim Securities Oncology Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tvardi Therapeutics to Present at the Guggenheim Securities Oncology Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/","og_locale":"en_US","og_type":"article","og_title":"Tvardi Therapeutics to Present at the Guggenheim Securities Oncology Conference - Pharma Trend","og_description":"HOUSTON–(BUSINESS WIRE)–#IPF–Tvardi Therapeutics, Inc. (\u201cTvardi\u201d), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced that the management team will present at the Guggenheim Securities Oncology Conference on Wednesday, February 8, 2023, in New York City as well as host one-on-one meetings throughout the day. Presentation Details: Date: Wednesday, February 8, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-03T13:02:16+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230203005028\/en\/808014\/21\/Tvardi-Master_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Tvardi Therapeutics to Present at the Guggenheim Securities Oncology Conference","datePublished":"2023-02-03T13:02:16+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/"},"wordCount":210,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230203005028\/en\/808014\/21\/Tvardi-Master_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/","url":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/","name":"Tvardi Therapeutics to Present at the Guggenheim Securities Oncology Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230203005028\/en\/808014\/21\/Tvardi-Master_Logo.jpg","datePublished":"2023-02-03T13:02:16+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230203005028\/en\/808014\/21\/Tvardi-Master_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230203005028\/en\/808014\/21\/Tvardi-Master_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-guggenheim-securities-oncology-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Tvardi Therapeutics to Present at the Guggenheim Securities Oncology Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53620"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53620\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}